NeuroPace (NPCE) Other Non-Current Assets (2020 - 2026)

NeuroPace's (NPCE) quarterly Other Non-Current Assets came in at $852000.0 in Q1 2026, up 598.36% year-on-year from $122000.0 in Q1 2025, and up 598.36% quarter-over-quarter from $122000.0 in Q4 2025.

NeuroPace (NPCE) Other Non-Current Assets (2020 - 2026) Analysis & Trends

NeuroPace's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $852000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 598.36% year-over-year to $852000.0 in Q1 2026; TTM through Mar 2026 was $852000.0, a 598.36% increase from a year earlier, with the FY2025 full-year figure at $122000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets climbed to $852000.0 in Q1 2026 per NPCE's latest filing, from $122000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $852000.0 in Q1 2026 and bottomed at $87000.0 in Q2 2025.
  • The 5-year median for Other Non-Current Assets is $122000.0 (2022), against an average of $162764.7.
  • Across the five-year window, Other Non-Current Assets slumped 66.67% in 2022 and soared 598.36% in 2026, its largest moves.
  • Year by year, Other Non-Current Assets stood at $122000.0 in 2022, then changed by 0.0% to $122000.0 in 2023, then changed by 0.0% to $122000.0 in 2024, then changed by 0.0% to $122000.0 in 2025, then surged by 598.36% to $852000.0 in 2026.
  • Per Business Quant, the three latest NPCE Other Non-Current Assets figures stand at $852000.0 (Q1 2026), $122000.0 (Q4 2025), and $120000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 3.17 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 738.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 285.90 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 828.89 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.25 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 164.00 Mn
10 NeuroPace 494.96 Mn 440.98 Mn 18.05 Mn 852,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 852,000.00
Dec 31, 2025 122,000.00
Sep 30, 2025 120,000.00
Jun 30, 2025 87,000.00
Mar 31, 2025 122,000.00
Dec 31, 2024 122,000.00
Sep 30, 2024 122,000.00
Jun 30, 2024 122,000.00
Mar 31, 2024 122,000.00
Dec 31, 2023 122,000.00
Sep 30, 2023 122,000.00
Jun 30, 2023 122,000.00
Mar 31, 2023 122,000.00
Dec 31, 2022 122,000.00
Sep 30, 2022 122,000.00
Jun 30, 2022 122,000.00
Mar 31, 2022 122,000.00
Dec 31, 2021 122,000.00
Sep 30, 2021 122,000.00
Jun 30, 2021 122,000.00